S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NASDAQ:ACTGAcacia Research Stock Price, Forecast & News

$3.97
0.00 (0.00 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.94
Now: $3.97
$4.01
50-Day Range
$3.79
MA: $3.99
$4.25
52-Week Range
$1.75
Now: $3.97
$4.46
Volume98,312 shs
Average Volume282,521 shs
Market Capitalization$193.38 million
P/E RatioN/A
Dividend YieldN/A
Beta0.53
Acacia Research Corporation, together with its subsidiaries, invests in intellectual property and related absolute return assets; and engage in the licensing and enforcement of patented technologies. It assists patent owners with the prosecution and development of their patent portfolios; protection of their patented inventions from unauthorized use; generation of licensing revenue from users of their patented technologies; and enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The company owns or controls the rights to various patent portfolios, which include U.S. patents and foreign counterparts covering technologies used in a range of industries. It has executed approximately 1,560 license agreements, and approximately 200 patent portfolio licensing and enforcement programs. Acacia Research Corporation was founded in 1992 and is headquartered in Newport Beach, California.
Read More
Acacia Research logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.36 out of 5 stars


Industry, Sector and Symbol

Industry Patent owners & lessors
Sub-IndustryResearch & Consulting Services
Current SymbolNASDAQ:ACTG
CUSIP00388130
Phone949-480-8300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.25 million
Book Value$3.47 per share

Profitability

Net Income$-17,110,000.00
Net Margins-205.81%

Miscellaneous

Employees13
Market Cap$193.38 million
Next Earnings Date8/10/2020 (Confirmed)
OptionableOptionable
$3.97
0.00 (0.00 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACTG News and Ratings via Email

Sign-up to receive the latest news and ratings for ACTG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Acacia Research (NASDAQ:ACTG) Frequently Asked Questions

How has Acacia Research's stock been impacted by COVID-19 (Coronavirus)?

Acacia Research's stock was trading at $2.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACTG stock has increased by 78.8% and is now trading at $3.97.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Acacia Research?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acacia Research in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Acacia Research
.

When is Acacia Research's next earnings date?

Acacia Research is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Acacia Research
.

How can I listen to Acacia Research's earnings call?

Acacia Research will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Acacia Research's earnings last quarter?

Acacia Research Corp (NASDAQ:ACTG) issued its earnings results on Monday, May, 11th. The business services provider reported ($0.07) EPS for the quarter. The business services provider earned $3.82 million during the quarter. Acacia Research had a negative return on equity of 1.50% and a negative net margin of 205.81%.
View Acacia Research's earnings history
.

What price target have analysts set for ACTG?

1 analysts have issued 1-year target prices for Acacia Research's stock. Their forecasts range from $5.00 to $5.00. On average, they expect Acacia Research's share price to reach $5.00 in the next year. This suggests a possible upside of 25.9% from the stock's current price.
View analysts' price targets for Acacia Research
.

Has Acacia Research been receiving favorable news coverage?

Media coverage about ACTG stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Acacia Research earned a news impact score of 0.8 on InfoTrie's scale. They also gave media coverage about the business services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.
View the latest news about Acacia Research
.

Are investors shorting Acacia Research?

Acacia Research saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 1,420,000 shares, an increase of 15.4% from the June 30th total of 1,230,000 shares. Based on an average daily volume of 448,400 shares, the short-interest ratio is presently 3.2 days. Approximately 3.0% of the shares of the company are sold short.
View Acacia Research's Current Options Chain
.

Who are some of Acacia Research's key competitors?

What other stocks do shareholders of Acacia Research own?

Who are Acacia Research's key executives?

Acacia Research's management team includes the following people:
  • Mr. Clayton J. Haynes, Consultant (Age 49)
  • Mr. Edward J. Treska, Consultant (Age 53)
  • Mr. Marc W. Booth, Chief Intellectual Property Officer (Age 60)
  • Mr. Phillip Mitchell Ph.D., Sr. VP - Engineering
  • Mr. Darren Miller, Sr. VP of Contracts - Legal

What is Acacia Research's stock symbol?

Acacia Research trades on the NASDAQ under the ticker symbol "ACTG."

Who are Acacia Research's major shareholders?

Acacia Research's stock is owned by a variety of institutional and retail investors. Top institutional investors include Capital Wealth Alliance LLC (0.34%), SeaCrest Wealth Management LLC (0.06%), SG Americas Securities LLC (0.05%), Eidelman Virant Capital (0.04%) and UBS Group AG (0.03%). Company insiders that own Acacia Research stock include Alfred Victor Jr Tobia, Marc W Booth and Robert B Stewart Jr.
View institutional ownership trends for Acacia Research
.

Which institutional investors are selling Acacia Research stock?

ACTG stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG.
View insider buying and selling activity for Acacia Research
.

Which institutional investors are buying Acacia Research stock?

ACTG stock was bought by a variety of institutional investors in the last quarter, including SeaCrest Wealth Management LLC, Eidelman Virant Capital, SG Americas Securities LLC, and Capital Wealth Alliance LLC. Company insiders that have bought Acacia Research stock in the last two years include Alfred Victor Jr Tobia, and Marc W Booth.
View insider buying and selling activity for Acacia Research
.

How do I buy shares of Acacia Research?

Shares of ACTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Acacia Research's stock price today?

One share of ACTG stock can currently be purchased for approximately $3.97.

How big of a company is Acacia Research?

Acacia Research has a market capitalization of $193.38 million and generates $11.25 million in revenue each year. Acacia Research employs 13 workers across the globe.

What is Acacia Research's official website?

The official website for Acacia Research is www.acaciaresearch.com.

How can I contact Acacia Research?

Acacia Research's mailing address is 4 PARK PLAZA SUITE 550, IRVINE CA, 92614. The business services provider can be reached via phone at 949-480-8300 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.